Company ProfilePremium

CAP-XX Limited

Company Profile Analysis

Ticker: CPX.L

ESOMAR 23 Corporate BadgeISO Certifications Badge
CAP-XX Limited - Company showcase

Year Founded & Workforce

1997

3,130,000 Employees

CAP-XX Limited logo

CAP-XX Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

CAP-XX Limited Overview

CAP-XX is a micro-cap Australian designer and manufacturer of thin, prismatic electric double-layer capacitors (supercapacitors). The products deliver short, high-current power bursts from very small, flat packages, down to 0.4 mm thick. Its core competence is high power density in space-constrained electronics: IoT nodes, wearables, professional headsets, smart meters, medical sensors and industrial devices. It is extending into modules for industrial back-up, grid stabilisation and data-centre applications.

After two decades as a largely IP-licensing story (Murata, AVX, TDK, Cornell Dubilier), CAP-XX bought Murata's supercapacitor production lines in 2019 and moved them to Sydney. It is now an owner-operator manufacturer. A costly, failed patent suit against Tesla-owned Maxwell Technologies (2023) ended the licensing-led era.

Under CEO Lars Stegmann (from 2023) and Chairman Dr Graham Cooley (from March 2025), the strategy is distribution-led volume growth. This runs through SCHURTER, Würth Elektronik, Farnell, RS, Waldom and DigiKey, alongside capacity upgrades. CAP-XX remains loss-making and dependent on equity raises and Australian R&D tax refunds.


What the company does. CAP-XX designs and manufactures supercapacitors and related energy-management systems. Its description of itself in the FY25 results and H1 FY26 interims is consistent: a designer and manufacturer of thin, flat supercapacitors and energy management systems.

Primary use: portable and small-scale electronic devices.

Growing use: larger applications such as automotive and renewable energy.

Claimed differentiator: very high power density and high energy storage capacity in a space-efficient prismatic package (FY25 results; H1 FY26 interims; Notes to Editors).

Business model. CAP-XX earns almost all its revenue from the sale of physical goods, recognised at a point in time.

FY25 split: sale of goods A$4.70m and "other services" A$0.235m (FY25 Note 5).

FY24 split: all A$4.59m was sale of goods.

Licensing: historically material, but no royalty or licence revenue appears as a separate line in FY24–FY25. As of H1 FY22, management noted no royalty or licensing revenue in that half, versus A$0.4m in H1 FY21.

The model has therefore moved from licensing-heavy to product-heavy.

Indicative revenue model mix (FY25):

Source: FY25 audited results, Note 5.

Non-revenue income. The P&L depends heavily on Australia's R&D Tax Incentive, booked as "other income":

  • FY25: A$1.75m

  • FY24: A$1.95m

In FY25 this exceeded gross profit (A$1.47m). The A$1.75m FY25 refund was received in cash in H1 FY26 (H1 FY26 cash flow; RNS 19 Dec 2025).

Value-chain position. CAP-XX sits in the passive-components tier:

  • It buys carbon/electrode materials, electrolytes, separators and packaging.

  • It manufactures cells at Seven Hills (Sydney).

  • It uses contract or partner capacity in Malaysia and China. The CEO's FY25 statement describes a diversified production base across Malaysia, China and Australia.

It sells through three routes:

  1. Global broadline and specialist distributors: Farnell (Avnet), RS Group, Waldom, DigiKey, JM elektronik, and from 2026 Würth Elektronik.

  2. A white-label partner, SCHURTER AG, which sells CAP-XX-made supercaps under its own brand.

  3. Direct design-wins with OEMs.

Customer types. CAP-XX sells to OEMs and ODMs in industrial electronics, IoT/wireless sensing, smart metering, professional headsets/audio, medical devices, wearables and solid-state storage. Most customers are reached through distribution. Disclosed design-wins include:

  • A "multinational conglomerate" (RNS 13 May 2025)

  • A "global semiconductor manufacturer" (RNS 5 Aug 2025)

  • A next-generation headphone platform with a major Asian manufacturer (FY25 Chairman's Statement)

  • A South African smart-metering client (Sharecast headline, 2024)

End-markets served (per company statements):

  • Professional headsets and industrial applications (cited as current traction)

  • Emerging defence, aviation and satellite opportunities (FY25 CEO statement)

  • IoT, industrial and mobility (FY25 Review of Operations)

  • Industrial and medical electronics via SCHURTER

  • Grid stabilisation and data centres for the developing Module range (Placing RNS, 30 Jul 2026)

Independent characterisation. CAP-XX is a sub-scale, single-technology component maker with a credible niche. Thin prismatic supercaps are a small sub-segment of a market dominated by cylindrical and module formats. Its revenue base (~US$3.4m) is tiny relative to the capital intensity of cell manufacturing. That is why gross margin collapsed from the low-40s% (FY21–FY23) to ~30% (FY24–FY25) as the business moved from licence-assisted revenue to owner-operated manufacturing with under-utilised fixed cost.

The investment case turns on three questions:

  1. Can distribution partners generate enough design-in volume to fill the ex-Murata lines?

  2. Can capacity upgrades restore margins?

  3. Can the company reach cash-flow breakeven before shareholder dilution becomes prohibitive?

The original target was breakeven in calendar 2026 (Trading Update, 7 May 2024). That timetable is now very unlikely given FY26 trading.

Strategy

Stated corporate strategy (themes paraphrased from FY25 Annual Report, H1 FY26 interims and 2026 placing RNS)

  1. Path to profitability and positive operating cash flow. Achieved through higher volumes, richer product mix, efficiency gains and accelerating design-wins (FY25 Outlook). The H1 FY26 CEO statement says the entire operational focus is on becoming cash-flow positive.

  2. Distribution-led commercial scaling. Build a global distribution network (Farnell/Avnet, RS, Waldom, DigiKey, JM elektronik, Würth Elektronik) to convert design-ins into a more predictable, recurring sales base (Placing RNS 2026).

  3. Strategic white-label partnership with SCHURTER. Co-branded and white-label supercaps with joint technology development (TCA, Mar 2025).

  4. Manufacturing scale-up and repatriation. Upgrade the DMF/DMT line, expand DMH to full production by FY27, build a clean coating room, and move Nation Gate production to Australia (Placing RNS 2026).

  5. Product-range broadening. SMT reflow-capable supercaps, 3V prismatics, ultra-thin DMH, and modules for grid and data-centre applications.

  6. Operational excellence and governance. Datapel WMS, Pipeliner CRM, MYOB integration, Power BI reporting, a new auditor and tighter financial controls (FY25; H1 FY26).

  7. Target-market focus. Professional headsets and industrial today; defence, aviation and satellite emerging (FY25 CEO statement).

Strategic initiatives register (last 24 months)

DateInitiativeTypeDetail / targetSource
May 2024Cost-reduction programmeCost>US$0.5m annualised opex savings. Breakeven target: calendar 2026.Trading Update, 7 May 2024
Jul 2024SCHURTER MoUPartnershipJoint technology and co-branded product developmentRNS, 15 Jan 2025
Nov 2024electronica showcaseGo-to-marketSCHURTER range of three products, 40+ variantsSCHURTER, Nov 2024
Jan 2025JM elektronik distributionChannelPoland: smart metering, medicalRNS, 17 Jan 2025
Mar 2025Waldom master distributionChannelMaster distributorRNS, 7 Mar 2025
Mar 2025SCHURTER Technology Cooperation AgreementPartnershipSynergies across R&D, manufacturing and salesRNS, 12 Mar 2025
Mar 2025Premier Farnell global distributionChannelGlobalRNS, 18 Mar 2025
Mar 2025Board restructuring and option grantsGovernance / incentivesCooley becomes ChairRNS, 19/26 Mar 2025
May 2025Website relaunchMarketing—RNS-R, 30 May 2025
Jun 2025RS Group global distributionChannelEMEA and North America reachRNS, 30 Jun 2025
FY25 – Sep 2025Datapel WMS / Pipeliner CRM / MYOB / Power BI integrationOperations / digitalReal-time reporting; inventory and cost-allocation accuracyFY25 results; RNS, 16 Sep 2025
Jul 2026Production-line investment programmeCapexDMF/DMT upgrade; DMH capacity to full production by FY27; clean coating roomPlacing RNS, 30 Jul 2026
Jul 2026Nation Gate line repatriationFootprintTransition customers to existing lines; manufacture in AustraliaPlacing RNS, 30 Jul 2026
2,026Würth Elektronik partnershipChannel / partnershipBroader set of global distribution agreementsPlacing RNS, 30 Jul 2026
2,026Module range developmentNew businessGrid stabilisation, data centresPlacing RNS, 30 Jul 2026

ESG/sustainability commitments: None formally announced in the materials reviewed.

Medium-term targets and guidance

TargetStatusSource
Breakeven in calendar 2026Set May 2024, conditional on billings growth continuing. Not reiterated in 2026 materials. H1 FY26 EBITDA loss of A$1.13m makes calendar-2026 breakeven highly unlikely.Trading Update, 7 May 2024; H1 FY26 interims
Cash-flow positiveStated as the overriding operational goal; no date givenH1 FY26 interims
DMH full productionBy FY27Placing RNS, 30 Jul 2026
Revenue growth accelerationBoard expects to accelerate revenue growth over the coming financial year (FY27) on new capacity and a broader range; no numeric guidancePlacing RNS, 30 Jul 2026

Products & Services

Because CAP-XX is single-segment, products are grouped by product family. Pricing is not publicly disclosed; products are sold through distributor list prices and OEM quotes. At the Murata transfer, CAP-XX stated it planned to keep Murata's existing pricing on DMF, DMT and DMH (EEPower, Dec 2019).

Ex-Murata thin supercapacitor families (manufactured at Seven Hills since 2020)

ProductDescription & key capabilitiesTarget customers / applicationsStatusSource
DMF seriesGeneral-purpose, very high power, long life. Very low ESR and wider operating voltage range. PCB-mountable.Wireless comms bursts, displays, haptics, GPS acquisition, industrial IoTIn production. 2026 placing funds a line upgrade on what the company calls a strongly performing line.EEPower Dec 2019; Placing RNS 30 Jul 2026
DMT seriesHigh-power, ultra-long-life, high-temperature. Thin enough for PCB assembly.Solid-state drives (power-loss protection), automotive, harsh environmentsIn production. Shares the DMF/DMT line being upgraded.EEPower Dec 2019; Placing RNS 2026
DMH seriesUltra-thin 0.4 mm supercapacitorSmartphones, smart cards, wearables, medical sensors, 3V coin-cell replacement, very thin IoTMurata launched it in Jan 2017. CAP-XX is expanding capacity, targeting full production by FY27.Sharecast Jan 2017; EEPower; Placing RNS 2026

Legacy CAP-XX prismatic supercapacitors

ProductDescriptionStatusSource
Thin prismatic single and dual-cell supercapacitors (historic GS/GW/HS/HW-type ranges)High-power-density flat packages. CAP-XX's original product line, made historically by contract manufacturers in Penang (Polar Twin Advance, Nationgate).The 2026 RNS says the "Nation Gate product line" will be relocated and its customers moved onto existing lines, with manufacturing repatriated to Australia.Annual Report 2009; Placing RNS 2026
DMV3V, 750 mF, 21 × 14 × 2.2 mm supercapacitorListed in secondary sourcesWikipedia mirror

New and developing platforms

ProductDescriptionDevelopment stageSource
SMT (surface-mount) supercapacitorsCapable of automated reflow-oven assembly. This removes a key barrier to high-volume adoption (manual or post-reflow placement).In development. Board is reviewing commercial applications, demand and revenue potential. Revenue contribution was originally guided for 2026.FY25 Review of Operations; Placing RNS 2026; Trading Update 7 May 2024
3V prismatic capacitorsSingle-cell 3V devices to simplify system integrationDevelopment, per FY25FY25 Review of Operations
Module rangeSupercapacitor modules for industrial uses, including grid stabilisation and data centres. Positioned as a more reliable, service-free alternative to battery systems.In developmentPlacing RNS, 30 Jul 2026
Clean coating room (enabling capex)New electrode-coating cleanroom applicable across all product linesFunded by the 2026 raisePlacing RNS, 30 Jul 2026

Energy-management systems / automotive

ProductDescriptionStatusSource
truckStartSupercapacitor engine-start module for trucks and cars. Reduces lead-acid battery wear, improves cold-cranking and acts as a regenerative-braking energy store.Developed in 2015. Current commercial volumes not disclosed.Company page; LSE news
High-energy cells and modules for automotive/large-scale useNew line developed and tested in the mid-2010sHistoric; commercial status not disclosedCompany corporate-development page

Partner-branded and licensed products

OfferingDescriptionStatusSource
SCHURTER-branded prismatic supercaps (white label)Three products in more than 40 variants. As thin as 0.4 mm; SCHURTER markets them as the world's thinnest high-power-density supercaps.Launched at electronica in Nov 2024. First shipment Jan 2025. As of Jul 2026: commercial and engineering contracts signed, white-label products launched, pipeline building.SCHURTER press release, Nov 2024; RNS 15 Jan 2025; Placing RNS 2026
Patent licences (Murata 2008, AVX 2016, TDK 2018, Cornell Dubilier 2019)Manufacturing and patent licencesHistoric. Current royalty income is not separately disclosed (see Section 2). Royalties in FY23 came mainly from AVX, with court proceedings over amounts owed.Company pages; FY23 results summary

Services

OfferingFY2025 revenueSource
Engineering / other services (recognised at a point in time)A$0.235mFY25 Note 5

Financial Narrative

Data provenance:

  • FY2024–FY2025 are from audited FY25 statements (FY24 restated).

  • FY2021–FY2023 P&L lines are from aggregator StockAnalysis, cross-checked with Investing.com and company commentary where possible.

  • FY2026 figures are unaudited headline numbers from the 30 Jul 2026 placing RNS. Only revenue is available for the full year.

"n/a" means not available in the sources reviewed; it is not an estimate.

Income statement

Notes:

FY26 revenue (A$5.24m, unaudited): The company describes this as an 11% increase on the prior year. Arithmetically, A$5.24m against audited FY25 revenue of A$4.94m is only +6.1%. The base used for the 11% claim is not explained in the RNS. This discrepancy should be resolved when the FY26 audited accounts are published.

FY22 EBITDA (−A$2.8m): As cited in the FY23 trading update (Alliance News, Aug 2023).

FY23 EBITDA (−A$1.3m): This is company "adjusted" EBITDA, excluding certain items (CEO-change costs flagged), so it is not comparable with FY24–FY25 statutory-basis EBITDA.

FY22–FY23 net losses: From Investing.com.

FY24 EBITDA: Restated (−A$5.11m) and includes ~A$2.26m legal expenses (FY25 Note 7).

EPS: In Australian cents (FY25 Note 33; Investing.com for FY22–FY23).

Margins (%)

Revenue CAGR:

  • FY2021–FY2025 (4 years): +4.8% p.a.

  • FY2021–FY2026 (5 years, FY26 unaudited): +5.0% p.a.

Both are analyst calculations from the table above.

Half-year detail (A$, unaudited, H1 FY26 interims):

Implied H2 revenue (analyst calculation): H2 FY25 = A$2.52m; H2 FY26 = A$2.61m (+3.6% YoY). Despite a 31% jump in H1 bookings and a A$2.8m backlog at 31 Dec 2025, H2 FY26 revenue was roughly flat on H1 FY26. That suggests capacity constraints, which is consistent with the stated rationale for the 2026 raise.

Balance sheet

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment / Revenue line

Segment / Revenue lineFY2023FY2024FY2025

Sale of goods (AUD Mn)

—4.594.70

Other services (AUD Mn)

—0.000.24

Total revenue (AUD Mn)

3.634.594.94

Total revenue YoY growth (%)

-34.726.57.5

Results by Segment and Segment Margins & Growth (%)

MetricFY2023FY2024FY2025

Gross profit (AUD Mn)

1.571.381.47

Gross margin (%)

43.330.029.7

Loss before tax (AUD Mn)

-5.56-6.14-3.93

Pre-tax margin (%)

-153.2-133.8-79.5

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025FY2026

Revenue (AUD Mn)

4.105.563.634.594.945.24

Revenue growth (%)

14.335.6-34.726.57.56.1

Cost of sales (AUD Mn)

2.343.032.063.213.47—

Gross profit (AUD Mn)

1.762.521.571.381.47—

Other income incl. R&D tax incentive (AUD Mn)

———1.952.14—

Research expenses (AUD Mn)

1.481.571.381.261.28—

EBITDA, company-defined (AUD Mn)

—-2.80-1.30-5.11-3.04—

Loss before tax (AUD Mn)

—-4.94-5.56-6.14-3.93—

Net loss after tax (AUD Mn)

—-4.94-5.56-6.14-3.93—

Basic & diluted EPS (A cents)

—-1.00-1.10-0.55-0.08—

Dividends per share (A cents)

000000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

42.945.443.330.029.7

EBITDA margin, company-defined (%)

—-50.4-35.8-111.3-61.6

Pre-tax margin (%)

—-88.8-153.2-133.8-79.5

Net margin (%)

—-88.8-153.2-133.8-79.5

Income Statement and Margin Analysis (%) (Half-Yearly)

MetricH1 FY2025H1 FY2026

Revenue (AUD Mn)

2.422.63

Gross profit (AUD Mn)

0.850.77

Gross margin (%)

35.029.1

Other income (AUD Mn)

1.110.94

Process & engineering (AUD Mn)

1.140.65

R&D expenses (AUD Mn)

0.600.66

Selling & marketing (AUD Mn)

0.300.40

G&A (AUD Mn)

1.491.42

EBITDA (AUD Mn)

-1.21-1.13

Net loss (AUD Mn)

-1.69-1.53

EPS (A cents)

-0.051-0.027

Balance Sheet and Share Count (m)

MetricFY2022FY2023FY2024FY2025

Total assets (AUD Mn)

—13.0610.2111.05

Cash & equivalents (AUD Mn)

—2.641.763.96

Short-term borrowings (AUD Mn)

—1.100.770.00

Long-term borrowings (AUD Mn)

—0.000.000.00

Lease liabilities, total (AUD Mn)

——2.011.74

Net debt incl. leases (AUD Mn)

——1.02-2.22

Net debt excl. leases (AUD Mn)

—-1.54-0.99-3.96

Total equity (AUD Mn)

6.846.534.456.70

Goodwill & intangibles (AUD Mn)

——0.000.15

Working capital, CA − CL (AUD Mn)

——2.975.28

Shares in issue (m)

——2,908.25,775.6

Cash Flow and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (AUD Mn)

———-4.04-2.35

of which R&D tax incentive received (AUD Mn)

———2.081.95

Capex incl. intangibles (AUD Mn)

———-0.02-0.19

Free cash flow (AUD Mn)

———-4.06-2.54

FCF margin (%)

———-88.4-51.4

Net equity raised (AUD Mn)

———3.975.83

Dividends paid (AUD Mn)

00000

Share buybacks (AUD Mn)

00000

Cash Flow History

DateCashSource

30 Jun 2025

A$3.96m

FY25 results

31 Oct 2025

A$1.5m (after A$0.85m non-recurring costs and creditor catch-up)

FY25 results

31 Dec 2025

A$2.92m (post refund)

H1 FY26 interims

Jul–Sep 2026

~£2.3m gross equity raised (≈ A$4.6m), mostly earmarked for production-line capex

Placing RNS; Perivan

Returns & Leverage Ratios (%)

RatioFY2024FY2025

ROE (%)

-111.8-70.5

ROA (%)

-52.8-37.0

ROIC (%)

ROIC (%)n/mn/m

Current ratio (x)

1.953.39

Debt/equity incl. leases (x)

0.620.26

Net debt/EBITDA (x)

Net debt/EBITDA (x)n/mn/m

Interest coverage, EBITDA/interest (x)

n/m

n/m

Asset turnover (x)

0.430.46

Days sales outstanding

5551

Days inventory outstanding

191104

Days payables outstanding

17399

Cash conversion cycle (days)

7256

Revenue by Region

RegionFY2023FY2024FY2025

Total revenue (AUD Mn)

3.634.594.94

Share Price History

DatePrice (p)ContextSource

Dec 2019

3.06

After Murata deal / placing announcement (−16% on the day)

Sharecast

Feb 2021

10.45

H1 FY21 results

Alliance News

2 Aug 2023

1.50

FY23 revenue warning (−14%)

Alliance News

18 Dec 2023

0.77

Maxwell verdict (−55%)

Alliance News

19 Feb 2024

0.62

Appeal dropped (−8.7%)

Sharecast

17 Feb 2025

0.12

H1 FY25; down 80% over 12 months

Alliance News

7 Nov 2025

0.27–0.28

FY25 results (−11% to −14%)

Sharecast; Alliance News

8 Jan 2026

0.22–0.24

Bid/offer

Fidelity

29 Jul 2026

0.22

Close before placing

Placing RNS

30 Jul 2026

0.15

Placing price

Placing RNS

~9 Oct 2026

0.1225

Latest delayed quote

London South East

Approx. Change by Horizon

HorizonApprox. changeBasis

1-year

−55% to −60%

~0.28–0.32p in Oct–Nov 2025 → 0.1225p

3-year

~−92%

~1.5p (Aug 2023) → 0.1225p

5-year

~−99%

~10p (2021) → 0.1225p

Capital Markets

MetricFY2024FY2025FY2026

Shares in issue at period end, m (FY26 = 30 Sep 2026)

2,908.25,775.67,424.0

Weighted average shares, m

1,118.14,774.0—

Valuation Multiples

MultipleCAP-XXBasisPeer comparison

Market cap

£9.09m ≈ A$18.4m

0.1225p × 7.424bn shares

—

P/E

n/m

Loss-making

n/m

EV/EBITDA

n/m

Negative EBITDA

n/m

Market cap / FY26 sales

~3.5x

A$18.4m / A$5.24m (unaudited)

Diversified passive-component peers typically trade at well under these levels on sales; no peer multiples verified this session

EV / FY26 sales

~2.6–3.2x

Market cap less estimated post-raise cash (range reflects undisclosed 30 Jun 2026 cash plus ~£2.3m gross raised)

—

P/B

~3.5x pre-raise; lower post-raise

£9.09m vs 31 Dec 2025 net assets A$5.30m (≈£2.6m); post-raise equity not yet reported

—

Capital Markets — Credit ratings

ItemStatus

Credit ratings (Moody's / S&P / Fitch)

Not rated

Financial debt

Nil at 30 Jun 2025 and 31 Dec 2025

Lease liabilities (31 Dec 2025)

A$0.45m current; A$1.15m non-current (Seven Hills lease)

Historic borrowings

R&D-advance-style facilities secured against tax refunds (FY24 borrowings A$0.77m; interest on R&D advance A$0.08m in FY25)

Share Price & Returns

DateAmountPriceNotesSource

Jan 2017

£2.43m

—

Development projects

Sharecast

Dec 2019

~£2.75m

~3p area

Murata lines

Sharecast

2023—

Discounted

Alongside CEO change

Wikipedia

FY24

A$3.97m net

—

Plus warrants issued

FY25 cash flow / SOCE

H2 CY2024

£2.75m (A$5.83m net in FY25 incl. other issues)

—

Oversubscribed; Cooley to 9.98%

Sharecast; FY25

Jul–Sep 2026

~£2.3m gross

0.15p

Two tranches plus retail offer; director fee conversion

Placing RNS; Perivan

Analyst Conclusions

Management guidance

Numeric guidance: None for FY27.

Qualitative guidance: The board expects expanded capacity and a broader product range to accelerate revenue growth over the coming financial year (Placing RNS, 30 Jul 2026).

DMH: Full production targeted by FY27.

Cash flow: Becoming cash-flow positive remains the overriding goal (H1 FY26 interims).

Breakeven: The calendar-2026 breakeven target (May 2024) has not been reiterated.

Consensus expectations

No sell-side consensus is available.

Bull case

  1. Order momentum is real and capacity is the bottleneck. FY26 bookings rose 34.9% to A$6.71m against revenue of A$5.24m, a book-to-bill of about 1.28. Backlog is A$3.42m. If the 2026 capex unlocks DMH and DMF/DMT output, FY27 revenue could step up materially without matching opex growth.

  2. Channel infrastructure is now in place. SCHURTER (an equity-aligned white-label partner), Würth, Farnell, RS, Waldom and DigiKey give a micro-cap the reach of a much larger supplier. Design-wins with a global semiconductor company and a multinational conglomerate suggest qualification credibility.

  3. Operating leverage plus margin repair. Gross margin was ~43–45% under a better mix in FY21–FY23. Repatriating Nation Gate production, the clean coating room and higher utilisation could restore margins toward the high-30s. At A$8–10m revenue, the R&D refund-supported cost base (opex excluding legal now about A$7m) could approach EBITDA breakeven.

Bear case

  1. Chronic cash consumption and dilution. Underlying H1 FY26 operating outflow was about A$2.7m. The ~£2.3m raised is mostly committed to capex. A further raise within 12 months is likely, at a share price already down about 99% over five years. The share count has risen 2.6x in about two years.

  2. Margin and scale problem may be structural. Gross margin fell to 29.1% in H1 FY26 even as revenue grew. Former licensees (AVX, TDK) and large incumbents compete. At about 1.5–2% of a ~US$200m prismatic niche, CAP-XX lacks the pricing power and procurement scale to earn adequate returns.

  3. Credibility and governance flags. Several factors raise execution risk:

    • The FY22 promise of positive EBITDA was missed.

    • The calendar-2026 breakeven aspiration was missed.

    • FY24 was restated and the auditor changed.

    • Two interim CFOs served in 2025.

    • The 2026 placing RNS contains apparent errors (the 11% vs 6.1% revenue growth claim; director percentages showing 48.68% vs 9.79%).

    • Core patents were invalidated.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
FY26 audited results and annual reportBy 31 Dec 2026 (FY25 precedent: early Nov)Confirmation of A$5.24m revenue and the growth basis; gross margin; cash at 30 Jun 2026; going-concern language; geographic split; remuneration
2026 AGM~Nov–Dec 2026Share authorities (signal of further raises); board independence
FY26 R&D tax refundH1 FY27 (Dec precedent)Amount (~A$1.5–2m indicative based on history)
Capex executionFY27DMF/DMT upgrade completion; DMH ramp to full production; clean room commissioning; Nation Gate transition without customer loss
H1 FY27 trading update and interims~Jan–Feb 2027Revenue conversion of backlog; book-to-bill; margin trajectory
Partner tractionOngoingSCHURTER project wins; Würth and distributor design-in volumes
Permanent CFO appointmentUnspecifiedFinance-function stability
Product launchesFY27SMT reflow-capable supercaps; Module range first orders (grid / data centre)
Further equity issuanceLikely within 12 months (analyst view)Pricing and discount; insider participation

Concluding analyst verdict

CAP-XX is a technically credible but financially fragile niche manufacturer. It now has its best commercial infrastructure in two decades and its weakest financial headroom.

What has improved. The 2023–2026 transformation under CEO Lars Stegmann and Chairman Graham Cooley has produced tangible operational gains:

  • Integrated ERP, WMS and CRM systems.

  • Better yields at Seven Hills.

  • Working-capital days roughly halved in FY25.

  • An enviable distribution roster for a company of its size, anchored by SCHURTER as both white-label partner and ~5% shareholder.

FY26 bookings growth of nearly 35% and a book-to-bill of about 1.3 are the most encouraging data points since the ex-Murata lines were commissioned in 2020.

What has not. The financial model is still unproven:

  • Revenue has compounded at only about 5% a year since FY21.

  • Gross margin has structurally reset to ~30% from the mid-40s.

  • Operating cash burn before the R&D refund runs at about A$5m+ a year against a ~A$18m market capitalisation.

  • The company has no financial debt but depends on discounted equity raises and Australian R&D refunds. Each raise compounds dilution: shares in issue have risen ~2.6x in two years.

The 2026 placing is a bet that capacity, not demand, is the binding constraint. That claim is plausible given flat H2 revenue against a rising backlog, but it remains unproven.

Governance. Signals are mixed. Insider alignment is high: directors hold ~11% and convert fees to equity. But finance-function turnover, a restatement, an auditor change and arithmetic inconsistencies in the most recent fundraising announcement warrant caution.

Verdict: Speculative / high risk — monitor for evidence of margin recovery. The equity is effectively an option on capacity-led revenue acceleration in FY27. The decisive evidence will come from:

  1. FY26 audited accounts: cash position and the basis of the growth claim.

  2. Whether H1 FY27 revenue moves materially above the ~A$2.6m per half run-rate.

  3. Whether gross margin recovers above ~35%.

Absent all three, further dilutive funding is likely before cash-flow breakeven, and the risk-reward stays unfavourable for all but highly risk-tolerant investors.


Source list (primary documents referenced)

  • CAP-XX RNS — Audited results for the year ended 30 June 2025 and Notice of AGM (7 Nov 2025)

  • CAP-XX RNS — Unaudited interim results for the period ended 31 Dec 2025 (2 Feb 2026)

  • CAP-XX RNS — Proposed Placing and Subscription to raise £2.0m and Retail Offer (30 Jul 2026)

  • CAP-XX RNS — Total Voting Rights (30 Sep 2026)

  • CAP-XX RNS — Management and board changes (7 Jan 2025)

  • CAP-XX RNS — Update on Patent Infringement (18 Dec 2023); Delaware judgment update (10 Jan 2024)

  • CAP-XX RNS — Trading Update (7 May 2024)

  • CAP-XX RNS — Interim Results H1 FY22 (23 Feb 2022) and H1 FY23 (28 Feb 2023); H1 FY23 Interim Report PDF

  • CAP-XX Annual Report 2009; CAP-XX corporate-development web page; CAP-XX FY23 results summary (IR page)

  • US Court of Appeals for the Federal Circuit, Order in No. 24-1411 (16 Feb 2024)

  • Alliance News / AJ Bell / Morningstar articles (2021–2026); Sharecast / Hargreaves Lansdown articles (2019–2026)

  • EEPower and eeNews Europe (Dec 2019, Murata line acquisition); SCHURTER press release (Nov 2024); Electronic Specifier (Nov 2024)

  • Mintz (Dec 2023, trial preview); Perivan (Aug 2026, fundraise)

  • Aggregators (flagged where used): StockAnalysis, Investing.com, Eulerpool, TradingView, Hargreaves Lansdown, Fidelity, London South East, TipRanks, Wikipedia

  • Market research (indicative only): IMARC Group, Market Data Forecast, Global Insight Services, Maximize Market Research, Global Info Research, QYResearch

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure (approx.)BackgroundShareholding post 3 Sep 2026% of 7,423,992,457 shares (analyst calc.)

Dr Graham Cooley

Non-Executive Chairman (since Mar 2025; NED since Jun 2024)

~2.3 years on board

Former CEO of ITM Power plc (hydrogen electrolysers). Clean-energy and technology-commercialisation track record.

726,973,0719.79%

Lars Stegmann

Chief Executive Officer (executive director)

CEO since 2023

Leads the distribution-led sales strategy. Prior roles and education not disclosed in materials reviewed.

17,130,8640.23%

Patrick (Pat) Elliott

Non-Executive Director (former Chairman for more than a decade, until Mar 2025)

10 years

Long-serving chair through the licensing and Maxwell eras

84,023,9631.13%

Peter Fraser

Non-Executive Director

Since ~2024

Subscribed in 2024 placing (stake then 0.2%)

15,757,5660.21%

Dr Anthony Sive

Non-Executive Director

Appointment date not disclosed in sources

Background not disclosed in sources

00.00%

Total

———

843,885,464

11.37%

Board & Management Changes

DateChangeSource

May 2023

Anthony Kongats (founder, CEO/Managing Director) exits

Wikipedia; H1 FY23 interim report

Jun 2024

Dr Graham Cooley appointed NED

Wikipedia

13 Jan 2025

Steen Feldskov (NED, ~3 years, electronic-component distribution expert) steps down at the AGM

RNS, 7 Jan 2025

19 Mar 2025

Board restructured: Cooley becomes Chairman; Elliott continues as NED; share options granted

RNS, 19 Mar 2025; FY25 Chairman's Statement

Executive Leadership Team

NameRoleDateBackgroundSource

Lars Stegmann

CEO

2023–present

See board table

—

Dr Alex Bilyk

Chief Technology Officer

—

Long-standing CAP-XX technologist (secondary source)

Wikipedia

Ariel Sivikofsky

Interim CFO (non-board)

Appointed 7 Jan 2025 for an initial six months

15 years as CFO of private and ASX companies (Netlinkz, InvestorFirst/Hub24, Macquarie Media). Formerly senior director, Deloitte Australia. B.Com, FCA (CA ANZ).

RNS, 7 Jan 2025

Anthony Guarna

Interim CFO

Appointed 9 Jun 2025; presented FY25 results in Nov 2025

Described as bringing extensive financial leadership experience

RNS, 9 Jun 2025; FY25 results

Previous CFO

Retired in 2024 (name not captured in sources)

2024—

Sharecast headline "CAP-XX chief financial officer to retire"

Company Secretary

Unnamed

—

Subscribing ~£10,000 in the 2026 raise

Placing RNS 2026

“—” = not publicly disclosed.

Major Shareholders

HolderApprox. stakeSource

Dr Graham Cooley (Chairman)

~9.79%

Placing RNS 2026; TVR 30 Sep 2026

SCHURTER AG (strategic partner)

~5%

Placing RNS, 30 Jul 2026

Patrick Elliott

~1.13%

As above

Other directors

~0.44% combined

As above

Other notifiable holders

Multiple "Holding(s) in Company" RNSs: Jul, Aug, Sep (x2) and Oct 2025; Dec 2025; 4 Sep 2026.

LSE RNS index

Competitive Landscape

Key Competitors

CompetitorHQRelevant product focusPositioning vs CAP-XX

Eaton (Bussmann supercapacitors)

Ireland/US

Cylindrical, coin, small prismatic and modules

Massive channel reach and breadth. CAP-XX is thinner and has higher power density in prismatic.

Kyocera AVX

US/Japan

SuperCapacitor modules, cells (a former CAP-XX licensee)

Licensee turned competitor; strong in medium/large formats

TDK

Japan

Small prismatic EDLCs (former CAP-XX licensee)

Licensee; scale and customer access

Murata

Japan

Exited supercapacitors (sold lines to CAP-XX in 2019)

Exit removed a competitor and gave CAP-XX its product base

Panasonic

Japan

Gold Capacitor (coin/cylindrical EDLC)

Coin-format incumbent in back-up power

Nippon Chemi-Con

Japan

DLCAP cylindrical EDLCs

Cylindrical, automotive and industrial

Taiyo Yuden / Elna

Japan

EDLCs and lithium-ion capacitors

Hybrid LIC alternative

KEMET (Yageo)

US/Taiwan

Supercapacitors (coin and cylindrical)

Broad passives catalogue

Musashi Energy Solutions

Japan

Lithium-ion capacitors

Higher-energy hybrid cells

Skeleton Technologies

Estonia/Germany

Curved-graphene ultracapacitors and modules (transport, grid)

Large-format modules; overlaps with CAP-XX's Module ambitions

LS Materials

South Korea

Ultracapacitor cells and modules

Large-format industrial and wind pitch

Vinatech

South Korea

EDLCs, small to large

Cost-competitive Asian supplier

UCAP Power (former Maxwell ultracapacitor business)

US

Large-format ultracapacitors

Legacy Maxwell product line; past litigation counterparty

Seiko Instruments

Japan

Thin chip EDLCs for wearables

Direct overlap in ultra-thin wearables

Peer Comparison FY2025

MetricCAP-XX (FY25)EatonKyocera AVXTDK

Supercap-related revenue

A$4.94m (100% of group)

———

Revenue growth

+7.5%

Not disclosed (segment)

Not disclosed (segment)

Not disclosed (segment)

Gross margin

29.7%

Not disclosed (segment)

Not disclosed (segment)

Not disclosed (segment)

R&D intensity

25.8% of revenue (research line only)

Group-level only

Group-level only

Group-level only

Form-factor focus

Thin prismatic, 0.4–2.2 mm

Broad

Broad / modules

Small prismatic

Manufacturing scale

Single main plant (Sydney) plus Asian partners

Global

Global

Global

“—” = not publicly disclosed.

Recent Developments

Not found in the review period: * layoffs, litigation, regulatory actions or guidance revisions (beyond the implicit lapse of the calendar-2026 breakeven aspiration). As of 9 Oct 2026, no FY26 audited results had been announced. TradingView had listed an expected date of 24 Sep 2026. FY25 results were released on 7 Nov 2025, and the AIM deadline for FY26 is 31 Dec 2026.

Company Snapshot

3,130,000

Employees

1997

Founded

Seven Hills, Australia

Headquarters

SWOT Analysis

Strengths

  • Owned, proven manufacturing assets. Ex-Murata lines with ~3x CAP-XX's prior capacity (Sharecast, Dec 2019). Seven Hills reported near-optimal stacker performance and improved yields in FY25 (FY25 results).
  • Demand momentum in orders. FY26 bookings A$6.71m (+34.9%). Backlog A$3.42m (+26.7%). H1 FY26 backlog up 132% YoY to A$2.8m. Sources: Placing RNS 2026; H1 FY26 interims.
  • Global distribution network built in 18 months. Waldom, Farnell, RS, JM elektronik and Würth, alongside DigiKey (RNSs, Jan 2025 – Jul 2026).
  • Strategic partner with equity alignment. SCHURTER holds ~5% and has launched white-label products (Placing RNS 2026).
  • Debt-free. Borrowings fully repaid in FY25; no financial debt at 31 Dec 2025 (FY25 results; H1 FY26 interims).
  • Recurring non-dilutive funding. Australian R&D tax incentive of A$1.75m in FY25 and A$1.95m in FY24 (FY25 Note 6).
  • Ultra-thin technology leadership. 0.4 mm DMH (EEPower; SCHURTER PR).
  • Insider alignment. Directors hold about 11.4%. The chair and a NED subscribed about £101k in 2026, and directors convert fees into equity (Placing RNS 2026).

Weaknesses

  • Persistent losses. FY25 net loss A$3.93m on A$4.94m revenue. H1 FY26 loss A$1.53m. Accumulated losses A$132.3m. Sources: FY25 results; H1 FY26 interims.
  • Margin erosion. Gross margin of 29.7% (FY25) and 29.1% (H1 FY26), versus 43–45% in FY21–FY23 (FY25 results; StockAnalysis).
  • Heavy dilution. Shares rose from 2.91bn (Jun 2024) to 7.42bn (Sep 2026) (FY25 Note 22; TVR 2026).
  • Finance-function instability. CFO retirement (2024), interim CFO in Jan 2025, a second interim CFO in Jun 2025, auditor change (Apr 2025) and a FY24 restatement (A$156k prior-period error) (RNSs; FY25 results).
  • Revenue volatility and project concentration. FY23 revenue fell 35%. Three long-term projects ended in FY25 (FY25 CEO statement).
  • Weakened IP moat. Core US patents ruled invalid in Dec 2023. The current portfolio is seven granted national patents (RNS Dec 2023; FY25).
  • Inconsistent disclosure. The FY26 revenue growth claim (+11%) does not match the arithmetic (+6.1%). The 2026 RNS director-percentage table contains apparent errors (Placing RNS 2026).

Opportunities

  • Capacity unlock. DMH full production by FY27 and the DMF/DMT upgrade target the stated constraint that, without new capacity, the company could not meet demand (Placing RNS 2026).
  • Module range for grid stabilisation and data centres. These are large markets where supercap modules replace batteries for ride-through (Placing RNS 2026).
  • SMT reflow-capable products, which could open high-volume automated assembly (FY25; Placing RNS 2026).
  • Defence, aviation and satellite demand for non-China supply (FY25 CEO statement).
  • Würth Elektronik and SCHURTER design-in conversion into recurring revenue (Placing RNS 2026).
  • Prismatic niche growth at about 11% CAGR to US$409m by 2031 (Global Info Research).
  • Margin recovery from repatriating the Nation Gate line and from the clean coating room's quality and yield benefits (Placing RNS 2026).

Threats

  • Funding risk. Underlying H1 FY26 operating outflow before the R&D refund was about A$2.7m. The 2026 RNS warned of liquidity mitigation if the second tranche failed (H1 FY26 cash flow; Placing RNS 2026).
  • Competition from much larger players, including former licensees AVX and TDK (company pages).
  • R&D tax incentive policy risk. The incentive is roughly equal to or larger than gross profit (FY25 Note 6).
  • Tariffs and trade tensions affecting electronics demand (FY25 CEO statement).
  • Technology substitution by thin batteries and hybrid capacitors (the hybrid supercap market was US$1.1bn in 2024, per QYResearch).
  • Share price at sub-penny levels (0.1225p), which constrains the cost of future equity raises (London South East quote, Oct 2026).
  • Key-person and execution risk in a small leadership team.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
30 Apr 2025Change of auditor (to SW Audit) RNSGovernance. Followed by FY24 prior-period restatement in FY25 accounts.
13 May 2025Design win with a multinational conglomerate RNS-RValidates the design-in pipeline
30 May 2025Updated website launched RNS-RMarketing refresh
9 Jun 2025Business update; Anthony Guarna appointed interim CFO RNS; TipRanksSecond interim CFO in six months
30 Jun 2025Global distribution agreement with RS Group plc RNSAdds a major broadline distributor
1 Jul 2025Issue of shares and director/PDMR shareholdings RNSEquity issuance / fee conversion
2 Jul 2025Holding(s) in company RNSRegister change
18 Jul 2025Update on SCHURTER collaboration RNSPartnership progress
25 Jul 2025Holding(s) in company RNSRegister change
31 Jul 2025Total voting rights RNSShare count update
5 Aug 2025Design win with a global semiconductor manufacturer RNS-R; FY25 Chairman's StatementHigh-profile design-in
7 Aug 2025Holding(s) in company RNSRegister change
10 Sep 2025Holding(s) in company RNSRegister change
16 Sep 2025Warehouse management system implemented RNSOperational controls
17 Sep 2025Holding(s) in company RNSRegister change
30 Oct 2025Holding(s) in company RNSRegister change
7 Nov 2025FY25 audited results: revenue A$4.94m (+7.6%), EBITDA −A$3.04m, cash A$3.96m. Q1 FY26 bookings +25.4%, billings +12.1%, backlog A$2.7m. Cash fell to A$1.5m by 31 Oct. RNS; Alliance News; SharecastShares fell ~11–14% to 0.27–0.28p on the day
10 Nov 2025Director/PDMR shareholding; investor presentation (Investor Meet Company) RNSInsider activity
14 Nov 2025Issue of shares and director/PDMR shareholding RNSEquity issuance
28 Nov 2025AGM held at Seven Hills; result of AGM; TVR RNSGovernance
10 Dec 2025Holding(s) in company RNSRegister change
19 Dec 2025Receipt of R&D tax credit (A$1.75m cash) RNS; H1 FY26 cash flowLiquidity boost
23 Jan 2026Notice of interim results and investor presentation RNS—
2 Feb 2026H1 FY26 interims: revenue A$2.63m (+9%); bookings A$3.4m (+31%); backlog A$2.8m (+132%); loss A$1.53m; cash A$2.92m; debt-free RNS; SharecastBookings momentum, but gross margin slipped to 29%
30 Jul 2026Proposed £2.0m placing and subscription plus up to £0.1m retail offer at 0.15p (31.8% discount to 0.22p close). FY26 unaudited: revenue A$5.24m, bookings A$6.71m (+34.9%), backlog A$3.42m (+26.7%). Würth Elektronik partnership disclosed. RNSMaterial dilution; capacity-constraint narrative
31 Jul 2026Result of placing and subscription RNSPlacing completed
3 Aug 2026First Admission: 869,599,016 placing shares (~£1.3m) Placing RNS timetable—
4 Aug 2026Retail offer oversubscribed; total gross ~£2.3m; notice of GM; TVR RNS; PerivanDemand above the £2.0m base
20 Aug 2026Change of GM virtual platform RNSAdministrative
26 Aug 2026Result of General Meeting (resolution for second tranche) RNS; TVRSecond Admission proceeded (TVR confirms enlarged capital)
28 Aug 2026Total voting rights RNS—
~3 Sep 2026Second Admission: second placing, subscription, retail and director-fee shares Placing RNS timetableCompletes the fundraise
4 Sep 2026Holding(s) in company RNSRegister change after the raise
30 Sep 2026TVR: 7,423,992,457 shares in issue RNSPost-raise denominator

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue rose from AUD 2.4 Mn in H1 FY2025 to AUD 2.6 Mn in H1 FY2026.
CAP-XX Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)H1 FY2025H1 FY2026
Revenue2.42.6
Gross profit0.90.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.